Synthon is an international pharmaceutical company, and a leader in the field of generic human medicines. Founded in 1991, Synthon has been working in biotechnology since 2007 and is developing rapidly into a specialty pharmaceutical company. We work to develop therapies that address the needs of people worldwide and help improve their health and well-being. With our portfolio of innovative medicines, we will provide treatment options for patients in selected therapeutic areas with high unmet medical needs. Through the provision of high-quality generic medicines, we make treatments more affordable and increase access to important remedies. Currently, our products are approved by regulatory agencies in more than 90 countries and marketed through strategic partnerships and – in dedicated areas – through direct sales.
Synthon’s head office is based in Nijmegen, the Netherlands, and the company has affiliates in eight other countries. In 2018, it recorded a turnover of EUR 301 million. The company employs around 1,800 staff of whom over 500 work in Nijmegen.
We are interested in result-oriented people with a sharp mind and entrepreneurial spirit, who can contribute to our ambition to provide solutions to the healthcare challenges of today and tomorrow.
During the different stages of Synthon’s generic drug development, you are responsible for the nonclinical safety activities related to drug substance and drug product projects, eventually leading to a successful submission of the registration dossier to authorities. This entails safety evaluations of the use of novel excipients and alternative routes of administration. You will also be responsible for qualification of impurities and supervision of outsourcing activities. You are expected to be up-to-date on technological developments and regulatory expectations. Furthermore, you are also responsible for nonclinical overviews and for answering questions from regulatory authorities and other sources about Synthon’s products.
Within a short timeframe after your appointment, we expect you to be able to work independently on several projects simultaneously. You will report to the vice president Clinical Research & Development and Toxicology.
Your letter and CV should show that you have:
⦁ A university degree in life sciences
⦁ Hands-on experience in regulatory toxicology, QSAR methods, non-clinical safety evaluation and (generic) drug development
⦁ Extensive knowledge on in vivo and in vitro toxicology (ideally at least 2-3 years’ experience in pharma industry or non-clinical CRO)
⦁ Outstanding command of the English language both in writing and speaking.
Registration as a toxicologist at the European Society of Toxicology is a plus.
In interviews you will be able to demonstrate that:
You can clearly explain and communicate to different stakeholders the toxicological essentials and requirements for generic drug substances and products. You are used to working on different topics and different projects simultaneously. You take initiative to get tasks accomplished. Next to that, you have a creative and pragmatic approach. You can handle both strategic and operational tasks in projects.
Please send your application before 8 August 2019. The first round of interviews will take place on 15 August 2019.
Contract hours: preferably full time.
Salary: depending on experience.
For further information, please contact Sandra van Os, vice president Clinical Research and Development and Toxicology at 024-372 7700. If you are interested in this challenging position, we look forward to your application.
You can apply via the apply button or link.